Drug-coated balloon treatment of coronary artery disease: A position paper of the Italian Society of Interventional Cardiology

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 3, 2014, Pages 427-435

  Cortese, Bernardo ^a   Berti, Sergio ^b   Biondi Zoccai, Giuseppe ^c   Colombo, Antonio ^d   Limbruno, Ugo ^e   Bedogni, Francesco ^f   Cremonesi, Alberto ^g   Silva, Pedro Leon ^a   Sgueglia, Gregory A ^h  

^a Interventional Cardiology   (Italy)

^b Fondazione Toscana Gabriele Monasterio   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^e MISERICORDIA HOSPITAL   (Italy)

^f ISTITUTO CLINICO SANT'AMBROGIO   (Italy)

^g Research Ettore Sansavini Health Science Foundation   (Italy)

^h S EUGENIO HOSPITAL   (Italy)

Author keywords

coronary artery disease; drug coated balloon; percutaneous coronary intervention

Indexed keywords

CORONARY ARTERY DISEASE; DRUG-COATED BALLOON; PERCUTANEOUS CORONARY INTERVENTION;

ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CATHETERS; CARDIOLOGY; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EQUIPMENT DESIGN; HUMANS; MYOCARDIAL INFARCTION; NEOINTIMA; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 84893751844     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25149     Document Type: Article

References (28)

1. Cortese B, Bertoletti A,. Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data. Int J Cardiol 2012; 161: 4-12.
2. Cortese B, Sgueglia GA, Granada JF,. Paclitaxel coated balloons, the time for awareness has come. Int J Cardiol 2013; 164: 1-2.
3. Cardiology ESO,. ESC Recommendations for Guidelines Production. Available at: http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/ rules-writing.aspx.
4. Gray WA, Granada JF,. Drug-coated balloons for the prevention of vascular restenosis. Circulation 2010; 121: 2672-2680.
5. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U,. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-2124.
6. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B,. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009; 119: 2986-2994.
7. Rittger H, Brachmann J, Sinha A-M, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J,. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES study. J Am Coll Cardiol 2012; 59: 1377-1382.
8. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A,. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial. Lancet 2013; 381: 461-467.
9. Cuculi F, Young M, Beeler R, Schoenenberger AW, Erne P,. Good efficacy of drug-eluting balloons in a mixed population of patients with coronary artery disease. J Invasive Cardiol 2012; 24: 151-153.
10. Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M,. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 2011; 4: 149-154.
11. Hehrlein C, Dietz U, Kubica J, Jørgensen E, Hoffmann E, Naber C, Lesiak M, Schneider H, Wiemer M, Tölg R, Richardt G,. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. Cardiovasc Revasc Med 2012; 13: 260-264.
12. Vaquerizo B, Serra A, Miranda-Guardiola F, Martínez V, Antoni Gõmez-Hospital J, Iñiguez A, Fernández E, Ramõn Rumoroso J, Bosa F, Otaegui I,. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: Insights from Spanish multicenter registry. J Interv Cardiol 2011; 24: 518-528.
13. Stella PR, Belkacemi A, Waksman R, Stahnke S, Torguson R, von Strandmann RP, Agostoni P, Sangiorgi G, Silber S, Valentine Investigators. The Valentines Trial: Results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention 2011; 7: 705-710.
14. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D,. Guidelines on myocardial revascularization. Eur Heart J 2010: 2501-2555.
15. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM, Stella PR,. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol 2012; 59: 2327-2337.
16. Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, Limbruno U,. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 2010; 96: 1291-1296.
17. Cortese B,. The PICCOLETO study and beyond. EuroIntervention 2011; 7 Suppl K: K53-6.
18. Põsa A, Nyolczas N, Hemetsberger R, Pavo N, Petnehazy O, Petrasi Z, Sangiorgi G, Gyöngyösi M,. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheter Cardiovasc Interv 2010; 76: 395-403.
19. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B,. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010; 99: 165-174.
20. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A,. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study. J Am Coll Cardiol 2012; 60: 2473-2480.
21. Sgueglia GA,. Innovative approaches to percutaneous bifurcation interventions using drug-eluting balloons. Minerva Cardioangiol 2012; 60: 531-537.
22. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX,. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention 2011: 7 Suppl K: K61-5.
23. Belkacemi A, Agostoni P, Voskuil M, Stella PR,. Coronary bifurcation lesions treated with the drug-eluting balloon: A preliminary insight from the DCBIUT study. EuroIntervention 2011; 7 Suppl K: K66-K69.
24. Sgueglia GA, Todaro D, Bisciglia A, Conte M, Stipo A, Pucci E,. Kissing inflation is feasible with all second-generation drug-eluting balloons. Cardiovasc Revasc Med 2011; 12: 280-285.
25. Sgueglia GA, Todaro D, Pucci E,. Drug-eluting balloon offers a new opportunity in percutaneous bifurcation interventions. EuroIntervention 2011; 7: 764-766; author reply 766-767.
26. Burzotta F, Sgueglia GA, Trani C, Talarico GP, Coroleu SF, Giubilato S, Niccoli G, Giammarinaro M, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F,. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: One-year clinical results of a prospective registry. J Invasive Cardiol 2009; 21: 532-537.
27. Bonaventura K, Leber AW, Sohns C, Roser M, Boldt LH, Kleber FX, Haverkamp W, Dorenkamp M,. Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease. Clin Res Cardiol 2012; 101573-84.
28. Peden S, Latimer L,. NICE Evaluation Pathway Programme for Medical Technologies, NHS, UK. June 2010, available at: www.nice.org.uk/guidance/MTG1.